Granite Group Advisors’s AstraZeneca AZN Stock Holding History

Granite Group Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Buy	+1,430	New	+$269K	0.16%	71
2026 Q1	–	Sell	-1,431	Closed	-$263K	–	87
2025 Q4	$263K	Hold	1,431	–	–	0.15%	75
2025 Q3	$219K	Buy	+1,431	New	+$217K	0.13%	75
2025 Q2	–	Sell	-2,138	Closed	-$314K	–	78
2025 Q1	$314K	Hold	2,138	–	–	0.22%	54
2024 Q4	$280K	Sell	2,138 -5	-0.2%	-$700	0.18%	58
2024 Q3	$334K	Hold	2,143	–	–	0.21%	53
2024 Q2	$334K	Buy	2,143 +387	+22%	+$58.2K	0.25%	52
2024 Q1	$238K	Hold	1,756	–	–	0.16%	81
2023 Q4	$238K	Buy	+1,756	New	+$228K	0.17%	77

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ISS

Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Granite Group Advisors's AZN Position: Q2 2026 in Review

Granite Group Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 1,430 shares worth $271K. The stake represents 0.16% of the portfolio and ranks #71 among its holdings. This is a return to the name: Granite Group Advisors previously reported a position in AZN as recently as Q4 2025.

Granite Group Advisors first reported a position in AZN in Q4 2023 and has held it in 9 quarters since. The position peaked at $334K in Q2 2024. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Granite Group Advisors held 1,430 shares of AstraZeneca worth $271K as of Q2 2026.
AstraZeneca was a new Granite Group Advisors position in Q2 2026.
AstraZeneca made up 0.16% of Granite Group Advisors's portfolio in Q2 2026, its #71 holding.
Granite Group Advisors first reported a position in AstraZeneca in Q4 2023 and has held it in 9 quarters since.
Granite Group Advisors's AstraZeneca position peaked at $334K in Q2 2024.
655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Granite Group Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.